title: Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist.
abstract: In order to design a selective M1 muscarinic agonist, we synthesized SR 95639A (morpholinoethylamino-3-benzocyclohepta-(5,6-c)-pyridazine, dihydrochloride), a semi-rigid analogue of the aminopyridazine antidepressant drug minaprine. SR 95639A displaced [3H]pirenzepine from its binding sites in rat hippocampal membranes with an IC50 value of 0.27 microM. It only weakly displaced [3H]N-methylscopolamine from cerebellar, cardiac and ileal membranes (10-48 microM), and, up to 100 microM, did not interact with the main other receptors of the rat brain. In rat isolated sympathetic ganglia, SR 95639A induced dose-dependent depolarizations which were antagonized by pirenzepine, and dose dependently suppressed the M current. These latter effects were also pirenzepine-sensitive. After i.p. or oral treatment in mice, SR 95639A never induced the classical cholinergic syndrome, up to lethal doses. Finally, SR 95639A (i.p. and p.o.) antagonized contralateral rotations induced by intrastriatal injection of pirenzepine, in mice. These results suggest that SR 95639A is a selective agonist at central muscarinic M1 receptors and may represent a useful tool for further characterization of the nature and function of muscarinic receptor subtypes.
authors: SANOFI Recherche, Montpellier, France.
authors: C
authors: C
authors: Schumacher
authors: R
authors: R
authors: Steinberg
authors: J P
authors: JP
authors: Kan
authors: J C
authors: JC
authors: Michaud
authors: J J
authors: JJ
authors: Bourguignon
authors: C G
authors: CG
authors: Wermuth
authors: P
authors: P
authors: Feltz
authors: P
authors: P
authors: Worms
authors: K
authors: K
authors: Biziere
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002946:Cisterna Magna; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007267:Injections; D008297:Male; D009025:Morpholines / Q000494:pharmacology*; D009126:Muscle Relaxation / Q000187:drug effects; D019832:N-Methylscopolamine; D010277:Parasympathomimetics / Q000494:pharmacology*; D010890:Pirenzepine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism; D012602:Scopolamine Derivatives / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects
chemical_list: D009025:Morpholines; D010277:Parasympathomimetics; D011724:Pyridazines; D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; C061233:morpholineoethylamino-3-benzocyclohepta(5,6-c)pyridazine; D010890:Pirenzepine; D019832:N-Methylscopolamine